{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470602164
| IUPAC_name = 1-(methoxymethyl)-4-oxo-N-propylquinoline-3-carboxamide
| image = Terbequinil_structure.png
| image2 = Terbequinil 3D ball.png
| alt2 = Ball-and-stick model of the terbequinil molecule
<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 113079-82-6
| ATC_prefix = none
| PubChem = 65916
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 59325
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0DH9WUS03O

<!--Chemical data-->
| C=15 | H=18 | N=2 | O=3 
| molecular_weight = 274.315 g/mol
| smiles = CCCNC(=O)C1=CN(C2=CC=CC=C2C1=O)COC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H18N2O3/c1-3-8-16-15(19)12-9-17(10-20-2)13-7-5-4-6-11(13)14(12)18/h4-7,9H,3,8,10H2,1-2H3,(H,16,19)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RIPDGZHPNKQLDC-UHFFFAOYSA-N
}}

'''Terbequinil''' ('''SR-25776''') is a [[stimulant]] and [[nootropic]] drug which acts as a partial [[inverse agonist]] at benzodiazepine sites on the [[GABAA receptor|GABA<sub>A</sub>]] [[Receptor (biochemistry)|receptor]]. In human trials it was found to partially reverse the [[sedative]] and [[amnestic]] effects of the hypnotic drug [[triazolam]] with only slight effects when administered by itself.<ref>Warot D, Danjou P, Douillet P, Keane P, Puech AJ. Cognitive impairments induced by triazolam in healthy volunteers: antagonism by a partial inverse agonist of benzodiazepine receptor. ''Therapie''. 1994 Jan-Feb;49(1):23-6. {{PMID|8091361}}</ref>

==See also==
* [[Radequinil]]

==References==
{{Reflist}}


{{Nootropics}}
{{GABAergics}}

[[Category:2-Quinolones]]
[[Category:Ethers]]
[[Category:Carboxamides]]
[[Category:GABAA receptor negative allosteric modulators]]